News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No Shit. neil reithinger is a total POS.......His company also:
https://eventusag.com/team/neil-reithinger/
Z
Why do I say that?.......Ahhhh......Cause that asshole neil reithinger KILLED all his shareholders. That's why.
And by doing that he basically killed all his credibility, AND created immense animosity towards peak pharma..... $PKPHD $PKPH.
The guy has shit for brains.
He absolutely RUINED the STRONG shareholder base, which was doing a great job giving support to the company/stock.
He also put a big black mark on his company eventus: https://eventusag.com/team/neil-reithinger/
If I had a company, I would avoid those assholes like the plague.
Z
Looks like this CEO of $PKPHD $PKPH Neil Reithinger is a real asshole:
https://eventusag.com/team/neil-reithinger/
Z
|
Followers
|
64
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
968
|
|
Created
|
09/26/12
|
Type
|
Free
|
| Moderators | |||
This company is a Shell, and recently got Current with the SEC/EDGAR, with 17 Filings.
These filings needed to be audited, and that's very expensive.
We're guessing they spent upwards of $500K.
The CEO is also involved with a Nasdaq Stock ( $ORGS ) that is currentl doing a Spin-Off.
This Spin-Off got $110M in Funding. (See 8K excerpt below)
So that Spin-Off will likely move into the $PKPH Shell, and thereby become a Nasdaq Stock.
Share Structure: AS: 300M, OS: 78M, Float: 36M
https://www.sec.gov/ix?doc=/Archives/edgar/data/1460602/000149315222030824/form8-k.htm
On November 4, 2022, Orgenesis Inc. (“Orgenesis”), Morgenesis LLC (“Morgenesis”), a recently formed subsidiary of Orgenesis holding all the assets of Orgenesis’ point of care services business for treating patients (“POCare Services”), and MM OS Holdings, L.P. (“MM”), an affiliate of Metalmark Capital Partners(“Metalmark Capital”), entered into a series of definitive agreements intended to finance, strengthen and expand Orgenesis’ POCare Services business. Morgenesis will use the investment to develop and expand its POCare Services business globally, but with an initial focus on the United States. This includes the development of additional POCare Centers, as well as the Orgenesis Mobile Processing Units and Labs (“OMPULs”). OMPULs will allow Orgenesis to provide biotech companies and hospital systems with global cGMP supply for their cell and gene therapy products at the point of care, with the ability to rapidly grow and scale cell and gene treatments to keep up with ever increasing demand. Metalmark Capital is a leading private equity firm that seeks to build long-term value through active and collaborative partnerships with business owners, founders and executives, with a focus on healthcare, agribusiness, and industrials.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1460602/000149315222030824/form8-k.htm
At any time until the consummation of a Company IPO or Change of Control (in each case, as defined in the LLC Agreement), MM may, in its sole discretion, elect to invest up to an additional $60,000,000 in Morgenesis (any such investment, an “Optional Investment”) in exchange for certain Class C Preferred Units of Morgenesis (the “Class C Units” and, together with the Class A Units and the Class B Units, the “Preferred Units”). $10,000,000 of such Optional Investment shall be to purchase Class C-1 Preferred Units based on an enterprise value of $125,000,000, with such enterprise value adjusted by any net debt as of such time; $25,000,000 of Optional Investment shall be to purchase Class C-2 Preferred Units based on an enterprise value of $156,250,000, with such enterprise value adjusted by any net debt as of such time; and $25,000,000 of Optional Investment shall be to purchase Class C-3 Preferred Units based on an enterprise value of $250,000,000, with such enterprise value adjusted by any net debt as of such time.
AI
